DK1697347T3 - 5- eller 6-substituerede benzimidazolderivater som inhibitorer af replikation af respiratorisk syncytial-virus - Google Patents

5- eller 6-substituerede benzimidazolderivater som inhibitorer af replikation af respiratorisk syncytial-virus

Info

Publication number
DK1697347T3
DK1697347T3 DK04804954.8T DK04804954T DK1697347T3 DK 1697347 T3 DK1697347 T3 DK 1697347T3 DK 04804954 T DK04804954 T DK 04804954T DK 1697347 T3 DK1697347 T3 DK 1697347T3
Authority
DK
Denmark
Prior art keywords
inhibitors
respiratory syncytial
syncytial virus
virus replication
benzimidazole derivatives
Prior art date
Application number
DK04804954.8T
Other languages
English (en)
Inventor
Jean-Francois Bonfanti
Koenraad Jozef Lodewijk Andries
Jerome Michel Claude Fortin
Philippe Muller
Frederic Marc Maurice Doublet
Christophe Meyer
Rudy Edmond Willebrords
Tom Valerius Josepha Gevers
Philip Maria Martha Bern Timmerman
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Application granted granted Critical
Publication of DK1697347T3 publication Critical patent/DK1697347T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK04804954.8T 2003-12-18 2004-12-20 5- eller 6-substituerede benzimidazolderivater som inhibitorer af replikation af respiratorisk syncytial-virus DK1697347T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03104806 2003-12-18
US56686704P 2004-04-30 2004-04-30
PCT/EP2004/053618 WO2005058874A1 (en) 2003-12-18 2004-12-20 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication

Publications (1)

Publication Number Publication Date
DK1697347T3 true DK1697347T3 (da) 2011-06-06

Family

ID=43646156

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04804954.8T DK1697347T3 (da) 2003-12-18 2004-12-20 5- eller 6-substituerede benzimidazolderivater som inhibitorer af replikation af respiratorisk syncytial-virus

Country Status (19)

Country Link
US (2) US20070093502A1 (da)
EP (1) EP1697347B1 (da)
JP (1) JP2007514719A (da)
KR (1) KR101123055B1 (da)
CN (1) CN1914196B (da)
AR (1) AR046770A1 (da)
AT (1) ATE499361T1 (da)
AU (1) AU2004298459B2 (da)
BR (1) BRPI0417273A (da)
CA (1) CA2548793A1 (da)
DE (1) DE602004031555D1 (da)
DK (1) DK1697347T3 (da)
HR (1) HRP20110313T1 (da)
MX (1) MXPA06007111A (da)
MY (1) MY142783A (da)
RU (1) RU2369606C2 (da)
SI (1) SI1697347T1 (da)
TW (1) TWI382981B (da)
WO (1) WO2005058874A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2444690T3 (es) * 2005-06-20 2014-02-26 Janssen R&D Ireland Bencimidazoles sustituidos con heterociclilaminoalquilo.
AR089568A1 (es) 2011-10-14 2014-09-03 Ambit Biosciences Corp Compuestos heterociclicos y sus metodos de usos
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201825465A (zh) 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
NZ748072A (en) 2017-03-20 2020-06-26 Forma Therapeutics Inc Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
AU2018352695A1 (en) 2017-10-19 2020-05-28 Effector Therapeutics, Inc. Benzimidazole-indole inhibitors of Mnk1 and Mnk2
CN113226356A (zh) 2018-09-19 2021-08-06 福马治疗股份有限公司 活化丙酮酸激酶r
US12053458B2 (en) 2018-09-19 2024-08-06 Novo Nordisk Health Care Ag Treating sickle cell disease with a pyruvate kinase R activating compound

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4025621A (en) * 1975-01-09 1977-05-24 Purdy Clarence L Method of curing and providing immunity from viral infections
CA1140119A (en) 1978-04-03 1983-01-25 Joseph Torremans N-heterocyclyl-4-piperidinamines
US4556660A (en) 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
US4634704A (en) 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
KR100190299B1 (ko) 1990-07-19 1999-06-01 디르크 반테 신규한 옥사졸릴 유도체
CA2376781A1 (en) * 1999-06-28 2001-01-04 Janssen Pharmaceutica N.V. Benzimidazoles and imidazopyridines as respiratory syncytial virus replication inhibitors
CN1210275C (zh) * 1999-06-28 2005-07-13 詹森药业有限公司 呼吸道合胞病毒复制抑制剂
DE60033859T2 (de) * 1999-06-28 2007-11-08 Janssen Pharmaceutica N.V. Hemmer des Respiratorischen Syncytial Virus
US20040157866A1 (en) * 2001-04-30 2004-08-12 Hisashi Takasugi Amide compounds
US7030150B2 (en) * 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
FR2833948B1 (fr) * 2001-12-21 2004-02-06 Sod Conseils Rech Applic Nouveaux derives de benzimidazole et leur utilisation en tant que medicament

Also Published As

Publication number Publication date
HRP20110313T1 (hr) 2011-05-31
WO2005058874A1 (en) 2005-06-30
EP1697347B1 (en) 2011-02-23
AU2004298459B2 (en) 2011-03-17
SI1697347T1 (sl) 2011-06-30
ATE499361T1 (de) 2011-03-15
JP2007514719A (ja) 2007-06-07
DE602004031555D1 (de) 2011-04-07
EP1697347A1 (en) 2006-09-06
AR046770A1 (es) 2005-12-21
MXPA06007111A (es) 2006-08-23
KR101123055B1 (ko) 2012-04-12
US20070093502A1 (en) 2007-04-26
CN1914196B (zh) 2012-01-25
US20090062278A1 (en) 2009-03-05
CN1914196A (zh) 2007-02-14
RU2369606C2 (ru) 2009-10-10
AU2004298459A1 (en) 2005-06-30
TWI382981B (zh) 2013-01-21
US8278455B2 (en) 2012-10-02
MY142783A (en) 2010-12-31
TW200531970A (en) 2005-10-01
KR20060127047A (ko) 2006-12-11
BRPI0417273A (pt) 2007-03-27
CA2548793A1 (en) 2005-06-30
RU2006125727A (ru) 2008-01-27

Similar Documents

Publication Publication Date Title
DK1723136T3 (da) Piperidinamino-benzimidazol-derivat som inhibitorer af replikation af respiratorisk syncytial virus
DK1697345T3 (da) Morpholinylholdige benzimidazoler som inhibitorer af respiratorisk syncytialvirus-replikation
NL301090I1 (nl) Entrectinib, dan wel tautomeren, of farmaceutisch aanvaardbare zouten daarvan
DK1979326T3 (da) Pyridin- og pyrimidinderivater som inhibitorer af histondeacetylase
DK1981875T3 (da) Substituerede indolylalkylaminoderivater som inhibitorer af histondeacetylase
DK1885684T3 (da) Derivater af 4-(2-amoni-1-hydroxyethyl)phenol som agonister af beta-2-adrenerg receptor
DK1562902T3 (da) 2-pyridonderivater som inhibitorer af neutrofilelastase
DK1196408T3 (da) Inhibitorer af respiratorisk syncytialvirusreplikation
DK1786799T3 (da) Hidtil ukendte phenylaminopyrimidinderivater som inhibitorer af bcr-abl-kinase
DK1196410T3 (da) Inhibitorer af respiratorisk syncytialvirusreplikation
DK1633726T3 (da) Pyrimidinderivater, der er egnede til behandling af CRTH2-formidlede sygdomme
DK2094676T3 (da) Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater
DK1761505T3 (da) Pyrimidin-urinstof-derivater som kinaseinhibitorer
DK1556375T3 (da) Flavonderivater som inhibitorer af cyklinafhængige kinaser
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
DK1954690T3 (da) Benzamidforbindelser, der er anvendelige som inhibitorer af histondeacetylase
DK1711177T3 (da) 1H-thieno-2,3-c-pyrazolderivater, der er egnede som kinase-I-inhibitorer
DK1699782T3 (da) Maleatsalte af et quinazolinderivat, hvilke maleatsalte er anvendelige som et antiangiogent middel
DK1697343T3 (da) Aminobenzimidazoler og benzimidazoler som inhibitorer af replikation af respiratorisk syncytialvirus
DK1697347T3 (da) 5- eller 6-substituerede benzimidazolderivater som inhibitorer af replikation af respiratorisk syncytial-virus
DK2043656T3 (da) Hidtil ukendt medicinsk anvendelse af triazinderivater
DK2240456T3 (da) Fremgangsmåde til fremstilling af 3, 5-dihydro-L, 3, 5-triazinderivater af metformin- og paraldehydderivater
DK1888613T3 (da) Fremgangsmåde til fremstilling af thiophenglycosidderivater
DK1900735T3 (da) Pyridazinylamin-derivater, anvendelsen deraf til fremstilling af picornavirus-inhibitorer
DK1786913T3 (da) Fremgangsmåde til fremstilling af diarylcycloalkylderivater